A Distinct Inflammatory Milieu in Patients with Right Heart Failure
Preprint
Abstract
Background: Right heart failure (RHF) is associated with worse clinical outcomes. In addition to hemodynamic perturbations, the syndrome of RHF involves liver congestion and dysfunction. The mechanisms that underlie heart-liver interactions are poorly understood and may involve secreted factors. As a first step to understand the cardiohepatic axis, we sought to elucidate the circulating inflammatory milieu in patients with RHF. Methods: Blood samples were collected from the IVC and hepatic veins during right heart catheterization from 3 groups of patients: 1) controls with normal cardiac function, 2) patients with heart failure (HF) who did not meet all criteria of RHF, and 3) patients who met prespecified criteria for RHF defined by hemodynamic and echocardiographic parameters. We performed multiplex protein assay to survey levels of several circulating markers and analyzed their association with mortality and need for left ventricular assist device or heart transplant. Finally, we leveraged publicly available single cell RNA sequencing (scRNAseq) data and performed tissue imaging to evaluate expression of these factors in the liver. Results: In this study of 43 patients, RHF was associated with elevated levels of a subset of cytokines/chemokines/growth factors compared to controls. In particular, soluble CD163 (sCD163) and CXCL12 were higher in RHF and predicted survival in an independent validation cohort. Furthermore, scRNAseq and immunohistochemistry of human liver biopsies suggest that these factors are expressed by Kupffer cells and may be liver derived. Conclusions: RHF is associated with a distinct circulating inflammatory profile. sCD163 and CXCL12 are novel biomarkers that can prognosticate patient outcomes. Future studies to define how these molecules influence HF phenotypes and disease progression may lead to new approaches to management of patients with RHF.Keywords
All Related Versions
- Published version: Circulation: Heart Failure, 16 (8), e010478.
This publication has 38 references indexed in Scilit:
- Combination of liver biopsy with MELD-XI scores for post-transplant outcome prediction in patients with advanced heart failure and suspected liver dysfunctionThe Journal of Heart and Lung Transplantation, 2015
- Stromal Cell–Derived Factor 1 as a Biomarker of Heart Failure and Mortality RiskArteriosclerosis, Thrombosis, and Vascular Biology, 2014
- Increased levels of plasma CXC-Chemokine Ligand 10, 12 and 16 are associated with right ventricular function in patients with idiopathic pulmonary arterial hypertensionHeart & Lung, 2014
- Divergent angiocrine signals from vascular niche balance liver regeneration and fibrosisNature, 2013
- Cardiac cachexia is associated with right ventricular failure and liver dysfunctionInternational Journal of Cardiology, 2013
- Abdominal Contributions to Cardiorenal Dysfunction in Congestive Heart FailureJACC, 2013
- Cardiohepatic Interactions in Heart FailureJACC, 2013
- Association of pre-operative interleukin-6 levels with Interagency Registry for Mechanically Assisted Circulatory Support profiles and intensive care unit stay in left ventricular assist device patientsThe Journal of Heart and Lung Transplantation, 2012
- Hepatic stellate cells express functional CXCR4Hepatology, 2009
- The rat macrophage scavenger receptor CD163: Expression, regulation and role in inflammatory mediator productionImmunobiology, 2006